2018-06-15 - Male - 61 Years old
714669
| Adverse reaction report number | 714669 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2018-06-15 |
| Latest received date | 2018-06-15 |
| Age | 61 Years |
| Gender | Male |
| Weight | 222 Pounds |
| Type of report | Spontaneous |
| Reporter type | Pharmacist |
| Source of report | Community |
| Report outcome | Unknown |
| Serious report? | Yes |
Reason for seriousness
| Death | |
| Disability | |
| Cogenital anomaly | |
| Life threateting | |
| Hospitalization | |
| Other medically important | Yes |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| OZEMPIC | SOLUTION SUBCUTANEOUS | Suspect | Subcutaneous | 0.5 Milligram | 1 every 1 Week(s) | Diabetes mellitus | |
| AMLODIPINE | TABLET | Concomitant | |||||
| ASPIRIN COATED | TABLET (ENTERIC-COATED) | Concomitant | |||||
| EZETIMIBE | TABLET | Concomitant | |||||
| GLICLAZIDE | TABLET | Concomitant | |||||
| JARDIANCE | Concomitant | ||||||
| LANSOPRAZOLE | CAPSULE, DELAYED RELEASE | Concomitant | |||||
| MORPHINE | NOT SPECIFIED | Concomitant | |||||
| PERINDOPRIL | NOT SPECIFIED | Concomitant | |||||
| PREGABALIN | CAPSULE | Concomitant | |||||
| ROSUVASTATIN | TABLET | Concomitant |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Retinal tear | |